AGILE is a trial platform testing multiple treatments for COVID-19. Like other platform trials, AGILE utilises a master protocol which facilitates testing of novel and experimental therapies for SARS-CoV-2 infection; each candidate under investigation forms a separate candidate specific trial which sits under the umbrella of the master protocol. This approach allows flexibility to test and evaluate different treatments at the same time.
